Cardiology Division Head
Women's College Hospital
University of Toronto
Dr. Udell is a Cardiologist and Clinician-Scientist at Women’s College Hospital and Toronto General Hospital; and Associate Professor of Medicine at the University of Toronto. Dr. Udell studies the efficacy and implementation of new therapies to prevent and treat coronary heart disease and heart failure. He conducts large population-based cohort studies at ICES and multicentre pragmatic CV outcome trials.
Disclosure(s): Amgen: Speaker/Honoraria (Terminated, July 31, 2023); AstraZeneca: Speaker/Honoraria (Terminated, May 31, 2023); Bayer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Terminated, July 31, 2024), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, July 31, 2024), Speaker/Honoraria (Terminated, July 31, 2024); Eli Lilly and Company: Speaker/Honoraria (Terminated, July 31, 2023); GlaxoSmithKline: Consultant/Advisory Board (Terminated, September 2, 2024), Speaker/Honoraria (Terminated, September 2, 2024); Janssen: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, December 31, 2022); Novartis: Consultant/Advisory Board (Terminated, January 31, 2021); Novavax: Consultant/Advisory Board (Terminated, January 31, 2023); Novo Nordisk: Consultant/Advisory Board (Ongoing); Sanofi: Consultant/Advisory Board (Terminated, December 31, 2022), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, December 31, 2022), Speaker/Honoraria (Terminated, December 31, 2022)
411 - CANADIAN PERSPECTIVES ON LATE BREAKING CLINICAL TRIALS
Sunday, October 27, 2024
8:00 AM – 9:00 AM PT